These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 7995274)

  • 21. Evidence-based treatment of hypertension in patients with type 2 diabetes.
    De Vriese A
    Acta Clin Belg; 2001; 56(2):96-102. PubMed ID: 11383319
    [No Abstract]   [Full Text] [Related]  

  • 22. [Arterial hypertension and type 2 diabetes].
    Scheen AJ; Estrella F; Weekers L
    Rev Med Liege; 1999 Oct; 54(10):789-95. PubMed ID: 10605312
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypertension and non-insulin dependent diabetes.
    Yudkin JS
    BMJ; 1991 Sep; 303(6805):730-2. PubMed ID: 1796956
    [No Abstract]   [Full Text] [Related]  

  • 24. [Hypertension in diabetes mellitus. Causes, follow-up and treatment].
    Klaus D
    Med Klin (Munich); 1994 Jun; 89(6):330-8. PubMed ID: 8072457
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of perindopril in hypertensive patients with or without type 2 diabetes mellitus, and with altered insulin sensitivity.
    Marre M; Leye A
    Diab Vasc Dis Res; 2007 Sep; 4(3):163-73. PubMed ID: 17907106
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The relationship of hyperinsulinaemia to the development of hypertension in type 2 diabetic patients and in non-diabetic subjects.
    Niskanen LK; Uusitupa MI; Pyörälä K
    J Hum Hypertens; 1991 Jun; 5(3):155-9. PubMed ID: 1920339
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systematic review of the effect of telmisartan on insulin sensitivity in hypertensive patients with insulin resistance or diabetes.
    Suksomboon N; Poolsup N; Prasit T
    J Clin Pharm Ther; 2012 Jun; 37(3):319-27. PubMed ID: 21848583
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New drugs and clinical trials in diabetes and hypertension.
    Nilsson P
    Exp Clin Endocrinol Diabetes; 1997; 105 Suppl 2():64-9. PubMed ID: 9288549
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypertension and insulin resistance: mechanisms an implications for treatment.
    Dodson PM
    J Hum Hypertens; 1991 Oct; 5(5):349-54. PubMed ID: 1770464
    [No Abstract]   [Full Text] [Related]  

  • 30. [Hypertension, insulin resistance and diabetes mellitus: pathophysiological interactions and therapeutic consequences].
    Schernthaner G
    Wien Klin Wochenschr; 1990 Dec; 102(24):707-12. PubMed ID: 1980767
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diabetes and hypertension in the elderly.
    Varricchio M; Paolisso G; Torella R; D'Onofrio F
    J Hypertens Suppl; 1988 Nov; 6(1):S41-4. PubMed ID: 3063792
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Insulin resistance and arterial hypertension. Major combination or a nice story?].
    Passa P
    Rev Prat; 1992 Sep; 42(14):1787-9. PubMed ID: 1480938
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment of non-insulin-dependent diabetic hypertensive patients with Ca2+ channel blockers is associated with increased platelet sensitivity to insulin.
    Touyz RM; Schiffrin EL
    Am J Hypertens; 1995 Dec; 8(12 Pt 1):1214-21. PubMed ID: 8998256
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hypertension in type II diabetes mellitus].
    Irsigler K
    Acta Med Austriaca; 1991; 18(3):57-60. PubMed ID: 1950378
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hypertension and insulin resistance in obese type 2 diabetic Wistar fatty rat].
    Suzuki M; Odaka H
    Nihon Rinsho; 2003 Jul; 61(7):1119-23. PubMed ID: 12877072
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carvedilol, metoprolol, and insulin resistance.
    Gonzalez-Feldman E
    JAMA; 2005 Mar; 293(10):1190; author reply 1190. PubMed ID: 15755941
    [No Abstract]   [Full Text] [Related]  

  • 37. [Misleading advertising claims about the indication of doxazosin (Cardura) for type 2 diabetes mellitus and hypertension].
    Hoogenberg K; van der Tuin J
    Ned Tijdschr Geneeskd; 2002 Nov; 146(44):2099-100. PubMed ID: 12448967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolic effects of beta-blockers: importance of dissociating newer from conventional agents.
    Sarafidis PA; Bakris GL
    J Hypertens; 2007 Jan; 25(1):249-52; author reply 252-3. PubMed ID: 17143201
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical significance of insulin resistance.
    Bell PM
    Diabet Med; 1996 Jun; 13(6):504-9. PubMed ID: 8799651
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of antihypertensive drugs losartan and levamlodipine besylate on insulin resistance in patients with essential hypertension combined with isolated impaired fasting glucose.
    Xiao WY; Ning N; Tan MH; Jiang XS; Zhou L; Liu L; Yi D; Wei P
    Hypertens Res; 2016 May; 39(5):321-6. PubMed ID: 26763851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.